Search

Helpdesk

Sales contact

Home > Resources > Working with patient associations: What is the key to a positive interaction?

Working with patient associations: What is the key to a positive interaction?

Patients insights Rare disease

Last updated: June 24, 2024

What rare disease patients and families want is a simpler life.
Discover here what makes the relationship between the members of the patients’ association and a company work so well.

Follow us on social media

Subscribe to our newsletter

You may also like

Navigating BYOD in Clinical Research: Insights for Clinical Trial Success

ePRO in early phase oncology trials: A revolution on the...

Patient-Reported Outcomes in early-phase oncology clinical trialsA Stepping Stone to...

Answering the Sustainability Call: Digital Health Technologies and eCOA

Kayentis secures Silver Medal in EcoVadis sustainability evaluation with significant...

Engage patients throughout the clinical trial journey

About the author

Marc Chaperon

Estelle brings 20+ years of experience in pre-clinical and clinical research from Top 5 Pharma and Biotech firms. Leading projects across Phases 1 to 4 in diverse therapeutic areas, she offers deep insights into clinical science, operations, and regulatory intricacies. Appointed as Chief Medical Officer at Kayentis in May 2019.

Meet us at the following events

SCOPE 2026

FEB 2-5 2026 • Orlando, USA

Booth #827 https://www.scopesummit.com/